Gainers
TransCode Therapeutics, Inc. RNAZ shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.
Fresh Tracks Therapeutics, Inc. FRTX shares rose 53.2% to $0.8887 in pre-market trading after the company announced its Board of Directors has approved a plan of liquidation and dissolution.
EBET, Inc. EBET shares rose 32.7% to $0.0702 in pre-market trading.
Exscientia plc EXAI shares jumped 25.6% to $6.36 in pre-market trading. Exscientia and Merck announced collaboration on AI-driven drug discovery in oncology, neuroinflammation, and immunology.
Histogen Inc. HSTO shares gained 21.5% to $0.48 in pre-market trading. Histogen shares fell 40% on Tuesday after the company announced its Board of Directors approved a Plan of Dissolution.
Rail Vision Ltd. RVSN rose 20.5% to $0.6020 in pre-market trading after gaining over 5% on Tuesday.
Avinger, Inc. AVGR shares surged 14.5% to $11.97 in pre-market trading on continued strength after the company on Monday announced the commercial launch of its Tigereye ST image-guided CTO crossing device.
Inhibikase Therapeutics, Inc. IKT rose 13.6% to $1.15 in pre-market trading after falling 33% on Tuesday.
Microbot Medical Inc. MBOT gained 13.3% to $1.86 in pre-market trading after falling 11% on Tuesday.
Cheche Group Inc. CCG shares climbed 8.9% to $35.25 in pre-market trading after falling 56% on Tuesday.
Losers
ARS Pharmaceuticals, Inc. SPRY fell 46.8% to $3.51 in pre-market trading after the FDA issued a Complete Response Letter for ARS Pharma's neffy® Epinephrine nasal spray, with request for additional study.
Connexa Sports Technologies Inc. CNXA shares fell 30.2% to $0.1375 in pre-market trading after jumping 160% on Tuesday.
Bird Global, Inc. BRDS shares fell 19.5% to $1.15 in pre-market trading. Bird Global shares jumped more than 103% on Tuesday after the company announced its purchase of micromobility operator Skinny Labs for $19 million.
TD Holdings, Inc. GLG fell 13.2% to $0.15 in pre-market trading after gaining 7% on Tuesday.
AgileThought, Inc. AGIL shares fell 12.5% to $0.1471 in pre-market trading after gaining 14% on Tuesday.
Elutia Inc. ELUT fell 9.1% to $1.50 in pre-market trading after jumping 33% on Tuesday. The company announced a $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share.
Digital Transformation Opportunities Corp. DTOC fell 8.3% to $12.56 in pre-market after dipping 53% on Tuesday.
Cybin Inc. CYBN fell 6.3% to $0.4119 in pre-market trading. Hedge fund owner Steve Cohen recently invested $19 million in the company.
Revance Therapeutics, Inc. RVNC fell 5.8% to $13.01 in pre-market trading. Revance Therapeutics shares fell 17% on Tuesday after the company said it commenced a plan to exit the OPUL payments business and expects to record a restructuring charge of up to $7 million.
Rail Vision Ltd. RVSN fell 4.1% to $0.47 in pre-market trading after gaining over 5% on Tuesday.
Now Read This: General Mills, FedEx And 3 Stocks To Watch Heading Into Wednesday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.